Zobrazeno 1 - 9
of 9
pro vyhledávání: '"M Mitchell Lindsay"'
Autor:
David Carrick, Caroline Haig, Nadeem Ahmed, Samuli Rauhalammi, Guillaume Clerfond, Jaclyn Carberry, Ify Mordi, Margaret McEntegart, Mark C. Petrie, Hany Eteiba, Stuart Hood, Stuart Watkins, M. Mitchell Lindsay, Ahmed Mahrous, Paul Welsh, Naveed Sattar, Ian Ford, Keith G. Oldroyd, Aleksandra Radjenovic, Colin Berry
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 2 (2016)
BackgroundThe time course and relationships of myocardial hemorrhage and edema in patients after acute ST‐segment elevation myocardial infarction (STEMI) are uncertain. Methods and ResultsPatients with ST‐segment elevation myocardial infarction t
Externí odkaz:
https://doaj.org/article/e666549c6508461eafff8cd3f78750e7
Autor:
Niels R Holm, Timo Mäkikallio, M Mitchell Lindsay, Mark S Spence, Andrejs Erglis, Ian B A Menown, Thor Trovik, Thomas Kellerth, Gintaras Kalinauskas, Lone Juul Hune Mogensen, Per H Nielsen, Matti Niemelä, Jens F Lassen, Keith Oldroyd, Geoffrey Berg, Peteris Stradins, Simon J Walsh, Alastair N J Graham, Petter C Endresen, Ole Fröbert, Uday Trivedi, Vesa Anttila, David Hildick-Smith, Leif Thuesen, Evald H Christiansen, Mitchell Lindsay, Markku Eskola, Hannu Romppanen, Tholmas Kellerth, Lisette O Jensen, Rikard B A Linder, Markku Pentikainen, Anders Hervold, Adrian Banning, Azfar Zaman, James Cotton, Erlend Eriksen, Sulev Margus, Lone J H Mogensen, Kari Kervinen, Geoff Berg, Colm G Hanratty, Indulis Kumsars, Terje K Steigen, Alastair NJ Graham, Matthias Corbascio, Olli Kajander, Juha Hartikainen, Ves Anttila
Publikováno v:
Holm, N R, Mäkikallio, T, Lindsay, M M, Spence, M S, Erglis, A, Menown, I B A, Trovik, T, Kellerth, T, Kalinauskas, G, Mogensen, L J H, Nielsen, P H, Niemelä, M, Lassen, J F, Oldroyd, K, Berg, G, Stradins, P, Walsh, S J, Graham, A N J, Endresen, P C, Fröbert, O, Trivedi, U, Anttila, V, Hildick-Smith, D, Thuesen, L, Christiansen, E H & NOBLE investigators 2020, ' Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis : updated 5-year outcomes from the randomised, non-inferiority NOBLE trial ', Lancet, vol. 395, no. 10219, pp. 191-199 . https://doi.org/10.1016/S0140-6736(19)32972-1
Holm, N R, Mäkikallio, T, Lindsay, M M, Spence, M S, Erglis, A, Menown, I B A, Trovik, T, Kellerth, T, Kalinauskas, G, Mogensen, L J H, Nielsen, P H, Niemelä, M, Lassen, J F, Oldroyd, K, Berg, G, Stradins, P, Walsh, S J, Graham, A N J, Endresen, P C, Fröbert, O, Trivedi, U, Anttila, V, Hildick-Smith, D, Thuesen, L, Christiansen, E H & NOBLE investigators 2020, ' Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis : updated 5-year outcomes from the randomised, non-inferiority NOBLE trial ', The Lancet, vol. 395, no. 10219, pp. 191-199 . https://doi.org/10.1016/S0140-6736(19)32972-1
Holm, N R, Mäkikallio, T, Lindsay, M M, Spence, M S, Erglis, A, Menown, I B A, Trovik, T, Kellerth, T, Kalinauskas, G, Mogensen, L J H, Nielsen, P H, Niemelä, M, Lassen, J F, Oldroyd, K, Berg, G, Stradins, P, Walsh, S J, Graham, A N J, Endresen, P C, Fröbert, O, Trivedi, U, Anttila, V, Hildick-Smith, D, Thuesen, L, Christiansen, E H & for the NOBLE study investigators 2020, ' Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis : updated 5-year outcomes from the randomised, non-inferiority NOBLE trial ', The Lancet, vol. 395, no. 10219, pp. 191-199 . https://doi.org/10.1016/S0140-6736(19)32972-1
Holm, N R, Mäkikallio, T, Lindsay, M M, Spence, M S, Erglis, A, Menown, I B A, Trovik, T, Kellerth, T, Kalinauskas, G, Mogensen, L J H, Nielsen, P H, Niemelä, M, Lassen, J F, Oldroyd, K, Berg, G, Stradins, P, Walsh, S J, Graham, A N J, Endresen, P C, Fröbert, O, Trivedi, U, Anttila, V, Hildick-Smith, D, Thuesen, L, Christiansen, E H & NOBLE investigators 2020, ' Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis : updated 5-year outcomes from the randomised, non-inferiority NOBLE trial ', The Lancet, vol. 395, no. 10219, pp. 191-199 . https://doi.org/10.1016/S0140-6736(19)32972-1
Holm, N R, Mäkikallio, T, Lindsay, M M, Spence, M S, Erglis, A, Menown, I B A, Trovik, T, Kellerth, T, Kalinauskas, G, Mogensen, L J H, Nielsen, P H, Niemelä, M, Lassen, J F, Oldroyd, K, Berg, G, Stradins, P, Walsh, S J, Graham, A N J, Endresen, P C, Fröbert, O, Trivedi, U, Anttila, V, Hildick-Smith, D, Thuesen, L, Christiansen, E H & for the NOBLE study investigators 2020, ' Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis : updated 5-year outcomes from the randomised, non-inferiority NOBLE trial ', The Lancet, vol. 395, no. 10219, pp. 191-199 . https://doi.org/10.1016/S0140-6736(19)32972-1
BACKGROUND: Percutaneous coronary intervention (PCI) is increasingly used in revascularisation of patients with left main coronary artery disease in place of the standard treatment, coronary artery bypass grafting (CABG). The NOBLE trial aimed to eva
Autor:
David, Carrick, Caroline, Haig, Nadeem, Ahmed, Margaret, McEntegart, Mark C, Petrie, Hany, Eteiba, Stuart, Hood, Stuart, Watkins, M Mitchell, Lindsay, Andrew, Davie, Ahmed, Mahrous, Ify, Mordi, Samuli, Rauhalammi, Naveed, Sattar, Paul, Welsh, Aleksandra, Radjenovic, Ian, Ford, Keith G, Oldroyd, Colin, Berry
Publikováno v:
Circulation. Cardiovascular Imaging
Supplemental Digital Content is available in the text.
Background— The success of coronary reperfusion therapy in ST-segment–elevation myocardial infarction (MI) is commonly limited by failure to restore microvascular perfusion. Methods and
Background— The success of coronary reperfusion therapy in ST-segment–elevation myocardial infarction (MI) is commonly limited by failure to restore microvascular perfusion. Methods and
Autor:
M Mitchell Lindsay, Francis G. Dunn
Publikováno v:
CARDIOLOGY CURRENT PERSPECTIVES
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fea0f0b423cba98019a3a7ad1de55a87
https://doi.org/10.4324/9780203213476_chapter_2
https://doi.org/10.4324/9780203213476_chapter_2
Publikováno v:
The Journal of invasive cardiology. 21(5)
We report the first case of extensive cellulitis and staphylococcal bacteremia with the subsequent development of a remote mycotic pseudoaneurysm in the ipsilateral brachial artery following right transradial coronary angiography in a diabetic patien
Autor:
M Mitchell Lindsay, Francis G. Dunn
Publikováno v:
British journal of sports medicine. 41(7)
Studies on exercise-induced left ventricular hypertrophy (LVH) in veteran athletes suggest the presence of abnormal diastolic filling and incomplete regression of LVH on cessation of exercise.Myocardial fibrosis occurs in exercise induced LVH in vete
Publikováno v:
Current opinion in cardiology. 19(4)
Purpose of review The clinical importance of fibrosis in hypertensive heart disease is now well recognized. However, the precise mechanisms involved in the pathophysiology and therefore the potential cardioreparative strategies are still not fully un
Publikováno v:
Hypertension (Dallas, Tex. : 1979). 40(2)
This study was designed to document noninvasively the pathological mechanisms responsible for myocardial fibrosis and to assess the clinical utility of plasma markers of collagen synthesis and degradation as screening tools for the assessment of fibr
Publikováno v:
NDT Plus
A 26-year-old female with haemolytic-uraemic syndrome (HUS) refractory to daily plasma exchange was successfully treated with rituximab. Subsequent testing confirmed the presence of mutations in genes encoding complement factor I and CD46. On Day 32